Skip to Content Facebook Feature Image

WuXi Biologics Included in S&P Global Sustainability Yearbook for Fourth Consecutive Year

Business

WuXi Biologics Included in S&P Global Sustainability Yearbook for Fourth Consecutive Year
Business

Business

WuXi Biologics Included in S&P Global Sustainability Yearbook for Fourth Consecutive Year

2026-03-02 11:21 Last Updated At:11:45

SHANGHAI, March 2, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced it has been included in the S&P Global Sustainability Yearbook 2026 ("Yearbook") in recognition of its strong performance in the 2025 Corporate Sustainability Assessment (CSA). The company was ranked top in its industry and achieved a Top 1% S&P Global CSA Score, marking the fourth consecutive year that WuXi Biologics has received this highest level of distinction.

The Yearbook aims to highlight individual companies — within a range of industries — that have demonstrated strong corporate sustainability performance, based on their S&P Global 2025 CSA Score. Out of the over 9,200 companies assessed in the 2025 CSA, only 848 companies, across 59 industries, were recognized as the top performers and selected for inclusion in Yearbook 2026.

Dr. Chris Chen, WuXi Biologics CEO and Chairman of the ESG Committee, commented, "Our strong performance in S&P Global's latest CSA and our inclusion in the Yearbook for the fourth consecutive year reflect WuXi Biologics' steadfast commitment to continuously enhancing our sustainability performance. We are a proven global leader in Green CRDMO, consistently delivering ESG excellence, enabling partners worldwide to fulfill their ESG commitments, and jointly working with all stakeholders to promote responsible practices throughout the entire value chain."

As a participant of the United Nations Global Compact (UNGC) and the Pharmaceutical Supply Chain Initiative (PSCI), WuXi Biologics proactively advocates sustainability and has earned widespread recognitions for its efforts. The company was granted an MSCI AAA Rating; awarded an EcoVadis Platinum Medal; listed in the Dow Jones Sustainability Indices (DJSI); named to the CDP "A List" for Climate Change,Water Security, and Supplier Engagement Assessment; given the highest negligible-risk rating by Sustainalytics, and recognized as a Sustainalytics industry and regional ESG top-rated company for five consecutive years; selected as a Constituent of the FTSE4Good Index Series; listed in the Hang Seng ESG 50 Index; and rated as Prime by ISS ESG Corporate Rating.

About WuXi Biologics

WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide.

With over 12,000 skilled employees in China, the United States, Ireland, Germany, Singapore and Qatar, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and cost-effective biologics discovery, development and manufacturing solutions. As of December 31, 2025, WuXi Biologics is supporting 945 integrated client projects, including 74 in Phase III and 25 in commercial manufacturing.

WuXi Biologics views Environmental, Social, and Governance (ESG) responsibilities as an integral component of our ethos and business strategy, and we aim to become an ESG leader in the biologics CRDMO sector. Our facilities use next-generation biomanufacturing technologies and clean-energy sources. We have also established an ESG committee led by our CEO to steer the comprehensive ESG strategy and its implementation, enhancing our commitment to sustainability.

For more information about WuXi Biologics, please visit: www.wuxibiologics.com 

Contacts
ESG
esg@wuxibiologics.com 

Media
PR@wuxibiologics.com 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

WuXi Biologics Included in S&P Global Sustainability Yearbook for Fourth Consecutive Year

WuXi Biologics Included in S&P Global Sustainability Yearbook for Fourth Consecutive Year

SHANGHAI, June 14, 2026 /PRNewswire/ -- The Gala Night of the 28th Shanghai International Film Festival (SIFF) was held in Shanghai today, bringing together filmmakers, industry professionals and audiences from around the world in celebration of cinema.

Running through June 20, this year's festival will present more than 420 films across over 1,600 screenings in Shanghai and cities throughout the Yangtze River Delta. As one of only 17 film festivals worldwide to hold official A-list classification from FIAPF, SIFF continues to serve as a major platform for international cinematic exchange.

The winners of the Golden Goblet Awards will be announced at the Golden Goblet Awards Ceremony of the 28th Shanghai International Film Festival on June 20.

A Night of Cinema Along the Huangpu River

The Gala Night transformed Shanghai into a vibrant stage for global cinema, welcoming filmmakers, actors and industry professionals from around the world. Golden Goblet Awards jurors, nominated filmmakers and representatives of major Chinese and international productions gathered on the red carpet, showcasing the festival's growing international profile and influence.

One of the evening's most significant moments was the presentation of the festival's honorary awards. Renowned actress and cultural ambassador Lisa Lu received the Lifetime Achievement Award, while acclaimed Chinese director Zhang Yimou was honored with the Outstanding Contribution to Chinese Cinema Award, recognizing their exceptional achievements and enduring contributions to the development of cinema.

The celebration once again highlighted Shanghai's unique role as a city where cinema, culture and international exchange converge.

Opening Film Afterpiece Makes World Premiere

This year's opening film, Afterpiece, made its world premiere as one of the festival's most anticipated events. Directed by Keane T.K. Wong and produced by Derek Yee, the film stars Stephen Fung, Chrissie Chau, Myolie Wu and Angela Yuen. The story follows a once-celebrated theatre director seeking creative redemption while navigating the increasingly blurred boundaries between performance and reality.

Developed under a Hong Kong film mentorship initiative pairing established filmmakers with emerging directors, Afterpiece reflects the continued transmission of creative talent across generations in Hong Kong cinema.

Members of the cast and creative team attended the Gala Night and participated in audience activities following the premiere screening.

International Jury Reflects Global Vision

Members of the Golden Goblet Awards jury met with the media in Shanghai ahead of this year's festival activities, representing filmmakers and industry professionals from around the world.

The seven-member Main Competition jury is chaired by acclaimed actor Tony Leung Chiu-wai and includes Chinese director Guan Hu, actress Xin Zhilei, Tunisian producer Dora Bouchoucha, Kyrgyz director Aktan Arym Kubat, Georgian filmmaker Déa Kulumbegashvili and Mexican director Fernanda Valadez.

"It is a great honor to serve as jury president of the 28th Shanghai International Film Festival. Cinema is the art of dreaming, and Shanghai is the very vessel on which the Chinese film dream set sail. I hold a few more tickets for this voyage—would you like to join me?" said Tony Leung Chiu-wai.

The jury's diverse composition reflects SIFF's longstanding commitment to fostering dialogue among filmmakers from different cultures and creative traditions.

A Truly Global Stage for Cinema

This year, SIFF received approximately 4,100 submissions from 125 countries and regions, setting a new record in the festival's history. Among nearly 3,000 eligible entries, 82 percent are world or international premieres, underscoring the festival's growing global influence and appeal.

Audience enthusiasm remained strong, with online ticket sales launching on June 5 and 250,000 tickets sold within the first 15 minutes.

Beyond screenings, SIFF continues to promote international collaboration through initiatives including SIFF PROJECT, the International Film & TV Market, industry forums and masterclasses. The Belt and Road Film Festival Alliance, initiated by SIFF, now includes 57 member institutions from 50 countries, further strengthening cooperation among film communities worldwide.

Chen Guo, Managing Director of Shanghai International Film & TV Events Center, said: "Our goal is to use the festival platform to help films transcend geographic, linguistic and cultural boundaries, encouraging deeper cultural dialogue and creative exchange among filmmakers and audiences from different parts of the world."

The International Film & TV Market will be held during the festival period, bringing together exhibitors, industry organizations and professionals from around the world to explore new opportunities in content creation, technological innovation and international cooperation.

For more information and the full festival schedule, please visit the official SIFF website at https://www.siff.com/english/

 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Gala Night of the 28th Shanghai International Film Festival Held in Shanghai

Gala Night of the 28th Shanghai International Film Festival Held in Shanghai

Recommended Articles